ASH 2025 Lymphoma Highlights: Epcoritamab, S1826, Mosunetuzumab & ctDNA | Dr. Sworder ASH 6 Mins Read Published: February 2, 2026Author: Dr. Brian Sworder, MD | City of HopeCategory: ASH 2025 | Lymphoma | Precision Oncology |…
Mosunetuzumab 1st Line Follicular Lymphoma Phase 2 [ASH 2023] Lymphoma 1 Min Read Under the lights of ASH 2023, the microphone poised to capture insights, Dr. Lorenzo Falchi, a medical doctor and lymphoma…
How effective is mosunetuzumab in treating lymphoma? – [Slides] Elizabeth Budde, MD 2023 reviews new therapies Lymphoma 27 Mins Read How effective is mosunetuzumab in treating lymphoma? – Elizabeth Budde, MD 2023 reviews new therapies By Elizabeth Budde, Md, PhD…
